On February 4, 2021, Congress introduced another CBD deregulation bill, H.R. 841 – Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, which, like H.R. 8179, legalizes marketing of hemp, CBD, or any other ingredient derived from hemp in a dietary supplement, provided the supplement satisfies other applicable requirements. Next, the bill goes to a House standing committee where experts will review, research, and revise the bill before voting on whether or not to send it to the House floor for a vote. Given that this bill was introduced early in the legislative cycle, observers are hopeful for movement under the current administration.

Be sure to read the other two cannabis articles in this month’s issue of MarkIt to Market®: “Watching the Pot™” and “GW Pharma Seeks Dismissal of Patent Suit Filed in Texas by Canopy Growth.”

This article appeared in the March 2021 issue of MarkIt to Market®. To view our past issues, as well as other firm newsletters, please click here.

© 2021 Sterne, Kessler, Goldstein & Fox P.L.L.C.